Visit this portal to explore Alfa Cytology’s collection of brochures, posters and flyers. Sort by literature type or category to find the materials that best suit your needs.
Results:
As a committed preclinical research service provider focused on cancer, Alfa Ctytology’s one-stop drug discovery services and a range of technology platforms will address the diverse needs of our clients, guaranteeing innovative and effective research results.
Learn More
At Alfa Cytology, we offer a comprehensive suite of preclinical services tailored to advance cancer research and drug development. Our one-stop preclinical platform provides end-to-end solutions, from disease modeling and diagnostic development to therapeutic evaluation - all under one roof.
Learn More
Alfa Cytology is dedicated to delivering comprehensive services for cancer vaccine development and preclinical research, fostering groundbreaking advancements in cancer immunotherapy.
Learn More
Alfa Cytology offers comprehensive guidelines for the development of breast cancer 3D spheroid models, designed to support researchers in accurately simulating the tumor microenvironment.
Learn More
Alfa Cytology offers Single B Cell Technology, a cutting-edge platform for the discovery of antibodies, enabling the identification and development of highly specific and effective therapeutic antibodies.
Learn More
Personalized Cancer Vaccines are offered by Alfa Cytology through their cutting-edge Neoantigen Discovery services, aiming to improve the effectiveness of cancer treatment for our customers.
Downloads
Alfa Cytology offers a comprehensive, one-stop service dedicated to the development of innovative therapies for breast cancer, ensuring personalized treatment options and improving overall outcomes.
Learn More
Alfa Cytology has established a unique technology platform for neoantigen peptide synthesis, offering high-quality, microgram-sized products with a very short lead time (7-10 days) for neoantigen peptide synthesis.
Learn More
Comprehensive miRNA profiling in a DEN-induced mouse model identifies biomarkers linked to hepatocellular carcinoma, with Alfa Cytology facilitating their potential use in diagnosis and treatment development.
Learn More
Alfa Cytology offers Single B Cell Technology, a cutting-edge platform for the discovery of antibodies, enabling the identification and development of highly specific and effective therapeutic antibodies.
Learn More
Alfa Cytology was proud to participate in Cancer R&D 2024, where they presented a session titled "Designing Your Preclinical Cancer Modeling Mouse Studies," showcasing their expertise and innovative approaches in developing and optimizing mouse models for preclinical cancer research.
Learn More
When choosing the right service provider for cancer therapy development, it’s essential to consider factors like experience, expertise, and support. Alfa Cytology is here to guide you through this critical selection process.
Downloads
PARP inhibitors are a groundbreaking cancer therapy significantly improved by PDX models, which reliably replicate tumor characteristics and drug responses, with Alfa Cytology specializing in custom PDX models for PARP inhibitor development.
Learn More
Alfa Cytology offers a cutting-edge High-Throughput Screening (HTS) platform to accelerate the discovery and development of new drugs for pancreatic cancer treatment, enabling researchers to efficiently identify promising therapeutic candidates.
Downloads
Alfa Cytology specializes in comprehensive end-to-end solutions for the discovery and development of small molecular drugs targeting leukemia, ensuring advancements in treatment and improving patient outcomes through innovative research.
Downloads
Specializing in the development of TCR-T cell therapy aimed at targeting and fighting pancreatic cancer, Alfa Cytology provides innovative solutions within the field of cancer treatment and research.
Downloads
The Cell Line Derived Xenograft (CDX) model plays a crucial role in oncology research. At Alfa Cytology, we have mastered the art and science of CDX model development, offering a comprehensive range of services tailored to meet the diverse needs of our clients.
Downloads
Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.
Copyright © 2025 Alfa Cytology. All rights reserved.
